The FBRI VTC Neuromotor Research Clinic
Launched by VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY · Oct 27, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The FBRI VTC Neuromotor Research Clinic is conducting a clinical trial to help children with conditions that affect their movement, such as cerebral palsy, autism, and brain injuries. The clinic uses an innovative approach called ACQUIREc Therapy, which focuses on assisting children who have difficulty using one side of their body more than the other. This therapy involves providing intense, play-based sessions that can last up to six hours a day, five days a week, for several weeks. The goal is to help children gain new motor skills by actively working on their weaker limbs in a fun and engaging way.
To participate in this trial, children must have some form of neuromotor impairment but should be in stable health. The research is currently open to all eligible children, regardless of age or gender. Families can expect a supportive environment where their child will receive specialized care aimed at improving their abilities. It's important to note that participation in the study is completely voluntary, and children will still receive therapy even if their families choose not to join the research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Neuromotor Impairment
- Exclusion Criteria:
- • fragile health
About Virginia Polytechnic Institute And State University
Virginia Polytechnic Institute and State University, commonly known as Virginia Tech, is a leading public research university renowned for its commitment to innovation and excellence in education. With a strong emphasis on interdisciplinary collaboration, Virginia Tech fosters advancements in various fields, including health sciences and engineering. The university actively engages in clinical research to address pressing health challenges, leveraging its state-of-the-art facilities and expert faculty to conduct rigorous clinical trials. Through its initiatives, Virginia Tech aims to enhance patient care and contribute to the scientific community's understanding of diverse health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roanoke, Virginia, United States
Patients applied
Trial Officials
Stephanie DeLuca, PhD
Principal Investigator
Virginia Polytechnic Institute and State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials